The Ministry of Health and Family Welfare has proposed significant changes to streamline the approval process for medical device manufacturing licences, a move aimed at accelerating domestic production while maintaining regulatory standards for quality, safety and performance.

According to a draft notification published in the Official Gazette, the proposed amendments seek to simplify and expedite the licensing framework for medical device manufacturers by introducing a more efficient regulatory process. The ministry stated that the reforms are intended to reduce approval timelines, improve ease of doing business and support the growth of India’s rapidly expanding medical devices sector.

The proposed changes are expected to benefit manufacturers across a range of medical device categories, including diagnostic equipment, implants, surgical instruments, monitoring devices and emerging healthcare technologies. While expediting approvals, the ministry emphasized that manufacturers will continue to be required to comply with established standards related to product quality, patient safety and regulatory performance requirements.

India’s medical devices industry has emerged as one of the fastest growing segments of the healthcare sector. According to industry estimates, the country’s medical devices market is currently valued at approximately USD 15 billion and is projected to reach USD 50 billion by 2030, driven by increasing healthcare expenditure, rising demand for advanced technologies and government initiatives promoting domestic manufacturing.

The proposed regulatory reforms align with the government’s broader objective of strengthening India’s position as a global manufacturing hub under initiatives such as Make in India and the Production Linked Incentive (PLI) Scheme for medical devices. Industry stakeholders have long advocated for simplified approval processes to improve competitiveness and encourage investment in research, development and manufacturing.

Healthcare experts believe that faster and more predictable licensing mechanisms can help accelerate innovation, reduce dependence on imports and improve the availability of medical technologies within the country. However, they also emphasize the importance of maintaining robust regulatory oversight to ensure patient safety and product reliability.

The Ministry of Health has invited stakeholder comments on the draft notification before finalizing the proposed amendments. Industry observers expect the reforms to enhance regulatory efficiency while supporting the continued growth of India’s medical devices ecosystem.

The latest proposal underscores the government’s commitment to balancing regulatory rigor with industry growth, with the goal of building a stronger, more self reliant and globally competitive medical devices sector.